After GAS5 has been downregulated in RA, the expression of HDAC4 in the cell is inhibited, thereby increasing the phosphorylation level of protein kinase B (AKT) in the AKT/mammalian target of rapamycin (mTOR) signaling pathway. This evidence concerns the gene AKT1 and rheumatoid arthritis.